Expanding Product Portfolio InBio's recent launches of advanced diagnostic technologies like ELISA 2.0 and MARIA for Foods, along with its mass spectrometry services, indicate a focus on innovative allergen detection solutions, presenting opportunities to supply new lab instruments, reagents, and custom testing kits.

Strategic Partnerships Collaborations with GX Group and LGC Standards showcase InBio's active engagement in expanding distribution channels and joint development opportunities, which could be leveraged to promote complementary products or technical support services.

Research & Development Focus A strong commitment to R&D and ongoing product enhancements suggest demand for cutting-edge laboratory equipment, premium testing materials, and specialized reagents that can enhance InBio's scientific capabilities.

Market Growth in Diagnostics InBio's recent entry into COVID-19 testing products and T cell-based diagnostics indicates potential for growth in infectious disease testing markets, creating opportunities to offer diagnostic instruments, consumables, and assay development services.

Global Outreach Potential With a dedicated European Business Manager and international partnerships, InBio shows expansion ambitions that could lead to sales opportunities in multinational lab chains, research institutions, and healthcare providers seeking allergen and allergy testing solutions.